736 related articles for article (PubMed ID: 18459518)
1. Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis.
Gupta AK; Cooper EA; Bowen JE
J Drugs Dermatol; 2008 Apr; 7(4):369-72. PubMed ID: 18459518
[TBL] [Abstract][Full Text] [Related]
2. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
Fleece D; Gaughan JP; Aronoff SC
Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
Dastghaib L; Azizzadeh M; Jafari P
J Dermatolog Treat; 2005 Feb; 16(1):43-6. PubMed ID: 15897167
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
Foster KW; Friedlander SF; Panzer H; Ghannoum MA; Elewski BE
J Am Acad Dermatol; 2005 Nov; 53(5):798-809. PubMed ID: 16243128
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis.
Gupta AK; Drummond-Main C
Pediatr Dermatol; 2013; 30(1):1-6. PubMed ID: 22994156
[TBL] [Abstract][Full Text] [Related]
6. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
Rademaker M; Havill S
N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
[TBL] [Abstract][Full Text] [Related]
8. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
9. Tinea capitis: predictive value of symptoms and time to cure with griseofulvin treatment.
Lorch Dauk KC; Comrov E; Blumer JL; O'Riordan MA; Furman LM
Clin Pediatr (Phila); 2010 Mar; 49(3):280-6. PubMed ID: 19487765
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes for tinea capitis in a skin of color population.
Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
[TBL] [Abstract][Full Text] [Related]
12. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the management of tinea capitis in children.
Kakourou T; Uksal U;
Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
[TBL] [Abstract][Full Text] [Related]
14. Tinea capitis in children: a systematic review of management.
Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
16. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
[TBL] [Abstract][Full Text] [Related]
17. Systemic antifungal therapy for tinea capitis in children.
González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis.
Grover C; Arora P; Manchanda V
Int J Dermatol; 2012 Apr; 51(4):455-8. PubMed ID: 22435438
[TBL] [Abstract][Full Text] [Related]
19. Systemic antifungal therapy for cutaneous infections in children.
Sethi A; Antaya R
Pediatr Infect Dis J; 2006 Jul; 25(7):643-4. PubMed ID: 16804437
[No Abstract] [Full Text] [Related]
20. Tinea capitis favosa in Poland.
Niczyporuk W; Krajewska-Kułak E; Łukaszuk C
Mycoses; 2004 Jun; 47(5-6):257-60. PubMed ID: 15189196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
